Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 6, 2002, Pages 1916-1921

  Kador, Peter F ^a   Takahashi, Yukio ^a   Akagi, Yoshio ^a   Neuenschwander, Heike ^a   Greentree, William ^a   Lackner, Petra ^a   Blessing, Karen ^a   Wyman, Milton ^a  

^a 986025 Nebraska Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DISEASE MODEL; DOG; DOSE RESPONSE; ENDOTHELIUM; ENUCLEATION; GALACTOSEMIA; IMAGE ANALYSIS; MALE; MICROANEURYSM; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINOPATHY; SUGAR INTAKE;

ANIMALS; CAPILLARIES; DIABETIC RETINOPATHY; DIET; DISEASE PROGRESSION; DOGS; ENDOTHELIUM, VASCULAR; GALACTOSE; GALACTOSEMIAS; MALE; PERICYTES; RETINAL VESSELS;

EID: 0036276478     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Diabetic retinopathy
2. Studies of retinal vascular patterns. I: Normal architecture
3. The mural cell in perspective
4. Studies on diabetic retinopathy. I: Retinopathy in a dog with spontaneous diabetes mellitus
5. Retinopathy in a dog following diabetes induced by growth hormone
6. Experimental diabetic retinopathy in dogs
7. Experimental galactosemia produces diabetic-like retinopathy
8. Diabeteslike pre-proliferative retinal changes in galactose-fed dogs
9. Diabeteslike proliferative retinal changes in galactose-fed dogs
10. Animal models of diabetes
11. The role of polyols in the pathophysiology of hypergalactosemia
12. Galactosemic biochemistry and pathogenesis
13. r-Galactonolactone in experimental galactosemic animals
14. Glucose dehydrogenase in dog lens and liver
15. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors
16. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors
17. Prevention of ocular diabetic complications by aldose reductase inhibitors
18. amelioration of diabetes-like retinal changes in galactose-fed dogs
19. Quantitative analysis of retinal vessel changes in galactose-fed dogs
20. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175
21. Hexitol production by canine retinal microvessels
22. Immunohistochemical distribution of al-dose reductase
23. Aldose reductase localization in dog retinal mural cells
24. Aldose reductase and polyol in cultured pericytes of human retinal capillaries
25. Polyol formation and NADPH-dependent reductases in cultured dog retinal capillary-pericytes and endothelial cells
26. Galactose induces apoptosis of dog retinal capillary pericytes, but not of endothelial cells
27. Alterations of lens protein synthesis in galactosemic rats
28. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes
29. Galactosemic animal models
30. Reversal of galactose cataract with Sorbinil in rats
31. Diabetic-like retinopathy: Early and late intervention therapies in galactose-fed rats
32. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes on the development of long-term complications in insulin-dependent diabetes mellitus
33. Progression of incipient diabetic retinopathy during good glycemic control
34. Polyol pathway metabolites in human cataracts: Correlation of circulating glycosylated hemoglobin content and fasting blood glucose levels
35. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia